UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reassuring Data for Cardiovascular Health After Switching a Boosted Protease Inhibitor to Dolutegravir

Clinical infectious diseases, 2023-10, Vol.77 (7), p.1010-1011

Wood, Brian R

2023

Volltextzugriff (PDF)

Metabolic dysfunction associated steatotic liver disease in persons with HIV: understanding the serious implications and renaming of ‘fatty liver disease’

AIDS (London), 2023-11, Vol.37 (14), p.2245-2246

Wood, Brian R.

2023

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study

Lancet Regional Health - Americas (Online), 2022-03, Vol.7, p.100159-100159, Article 100159

2022

Volltextzugriff (PDF)

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL

PloS one, 2012-11, Vol.7 (11), p.e50065-e50065

2012

Volltextzugriff (PDF)

Do Integrase Inhibitors Cause Weight Gain?

Clinical infectious diseases, 2020-03, Vol.70 (7), p.1275-1277

Wood, Brian R

2020

Volltextzugriff (PDF)

A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP)

Current HIV/AIDS reports, 2019-02, Vol.16 (1), p.113-119

2019

Volltextzugriff (PDF)

Nonoccupational Postexposure Prophylaxis (nPEP) Visits: Opportunities Beyond HIV PEP

International journal of infectious diseases, 2015-11, Vol.40 (C), p.131-132

Wood, Brian R

2015

Volltextzugriff (PDF)

Early adopters of long-acting injectable cabotegravir/rilpivirine: what lessons can we learn?

AIDS (London), 2024-03, Vol.38 (3), p.425-426

2024

Volltextzugriff (PDF)

Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or ‘PIP’ (postexposure prophylaxis in-pocket)

AIDS (London), 2020-03, Vol.34 (3), p.481-482

Wood, Brian R

2020

Volltextzugriff (PDF)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy

AIDS (London), 2020-12, Vol.34 (15), p.2319-2320

Wood, Brian R

2020

Volltextzugriff (PDF)

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir

PloS one, 2017-10, Vol.12 (10), p.e0181993-e0181993

2017

Volltextzugriff (PDF)

Management of Integrase Inhibitor-Associated Weight Gain: A Practical Clinical Approach

Current infectious disease reports, 2023-06, Vol.25 (6), p.101-109

Wood, Brian R.

2023

Volltextzugriff (PDF)

Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings

AIDS (London), 2021-07, Vol.35 (9), p.1505-1507

2021

Volltextzugriff (PDF)

Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide

Infectious disease clinics of North America, 2019-09, Vol.33 (3), p.693-705

Wood, Brian R

2019

Volltextzugriff (PDF)

Could Home Human Immunodeficiency Virus Self-Testing Ever Become a Game Changer?

Clinical infectious diseases, 2023-05, Vol.76 (9), p.1681-1684

2023

Volltextzugriff (PDF)

Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation

AIDS (London), 2023-03, Vol.37 (4), p.689-691

2023

Volltextzugriff (PDF)

Does Pneumocystis jirovecii pneumonia cause long-term deficits in lung function?

AIDS (London), 2023-07, Vol.37 (8), p.1333-1334

2023

Volltextzugriff (PDF)

Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases

Clinical infectious diseases, 2019-04, Vol.68 (9), p.1437-1443

2019

Volltextzugriff (PDF)

The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future

Current HIV/AIDS reports, 2021-04, Vol.18 (2), p.98-104

2021

Volltextzugriff (PDF)

Baseline HIV genotype drug resistance testing: is it time for more or less?

AIDS (London), 2022-08, Vol.36 (10), p.1449-1451

2022

Volltextzugriff (PDF)

Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?

Open forum infectious diseases, 2021-12, Vol.8 (12), p.ofab542-ofab542

2021

Volltextzugriff (PDF)

Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial

AIDS (London), 2022-07, Vol.36 (8), p.1191-1193

2022

Volltextzugriff (PDF)

Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study

PloS one, 2015-04, Vol.10 (4), p.e0124139-e0124139

2015

Volltextzugriff (PDF)

Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance

AIDS (London), 2021-07, Vol.35 (8), p.1305-1307

2021

Volltextzugriff (PDF)

Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Clinical infectious diseases, 2021-03, Vol.72 (6), p.913-919

2021

Volltextzugriff (PDF)

1 – 25 von 952

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(845)
Mit Volltextzugriff
(804)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(947)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Reassuring Data for Cardiovascular Health After Switching a Boosted Protease Inhibitor to Dolutegravir

Metabolic dysfunction associated steatotic liver disease in persons with HIV: understanding the serious implications and renaming of ‘fatty liver disease’

Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL

Do Integrase Inhibitors Cause Weight Gain?

A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP)

Nonoccupational Postexposure Prophylaxis (nPEP) Visits: Opportunities Beyond HIV PEP

Early adopters of long-acting injectable cabotegravir/rilpivirine: what lessons can we learn?

Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or ‘PIP’ (postexposure prophylaxis in-pocket)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir

Management of Integrase Inhibitor-Associated Weight Gain: A Practical Clinical Approach

Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings

Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide

Could Home Human Immunodeficiency Virus Self-Testing Ever Become a Game Changer?

Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation

Does Pneumocystis jirovecii pneumonia cause long-term deficits in lung function?

Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases

The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future

Baseline HIV genotype drug resistance testing: is it time for more or less?

Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?

Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial

Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study

Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance

Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Suchergebnisse filtern